Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834
- PMID: 35050368
- PMCID: PMC8914431
- DOI: 10.2337/dc21-2072
Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834
Comment in
-
Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.Diabetes Care. 2022 Feb 1;45(2):e43-e44. doi: 10.2337/dci21-0054. Diabetes Care. 2022. PMID: 35050370 No abstract available.
Comment on
-
Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?Diabetes Care. 2021 Aug;44(8):1826-1834. doi: 10.2337/dc21-0028. Epub 2021 Jun 26. Diabetes Care. 2021. PMID: 34175829
References
-
- Meek CL, Oram RA, McDonald TJ, Feig DS, Hattersley AT, Murphy HR; CONCEPTT Collaborative Group . Reappearance of C-peptide during the third trimester of pregnancy in type 1 diabetes: pancreatic regeneration or fetal hyperinsulinism? Diabetes Care 2021;44:1826–1834 - PubMed
-
- Djelmis J, Ivaniševic M, Desoye G, et al. . Higher cord blood levels of fatty acids in pregnant women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2018;103:2620–2629 - PubMed
-
- Horvaticek M, Djelmis J, Ivanisevic M, Oreskovic S, Herman M. Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial. Eur J Clin Nutr 2017;71:968–972 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical